Skip to content
Search

Latest Stories

Officials urged to treat all frontline clinicians equally

By Simon Dukes


Chief Executive

Pharmaceutical Services Negotiating Committee

FOR me, the genuine privilege of being the negotiator for community pharmacy in England is meeting and talking to so many dedicated people up and down the country.

Pharmacists and pharmacy teams are devoted to the welfare of their patients, and to the unique role they have in the com­munity. At a time of national crisis, the role of community pharmacy is vital.

As GPs and hospitals are deluged with increasing numbers of people infected with Covid-19, our ‘NHS on the high street’ – our network of 11,500 community pharmacies – becomes even more crucial to society. In fact, it becomes literally the differ­ence between life and death.

As they have since the beginning of the coronavirus outbreak – and will do until the end of it – pharmacists, pharmacy techni­cians, dispensing staff, drivers, and the wider teams are putting their wellbeing at risk every day to keep pharmacies open, dis­pensing medicines and advising and treating patients.

Despite warning signs online, in the national press and in the pharmacies telling them not to, many patients displaying the symptoms of the virus still turn up seeking help. With nowhere else to turn to, frightened and frustrated patients sometimes become violent and abusive.

With no other shops on the high streets currently open, phar­macies have also now become an increased target for criminals looking for cash or drugs.

Yet despite all this, our pharmacy teams continue to serve their communities. You would have thought, wouldn’t you, that our community pharmacies would be lauded? That they would be spoken of in the same breath as our GPs, medics, nurses and paramedics? But no, not for them the recognition that comes to other clinicians. Nor the funding.

Despite financial top-ups to the health sector prior to this outbreak, the government has cut funding in real terms to com­munity pharmacies every year since 2014 – and this is set to continue until 2024. And in the middle of this crisis, when com­munity pharmacies are dispensing medicines to the sick, vul­nerable and isolated, and providing much-needed advice and guidance to the worried well and unwell alike, the government still refuses to acknowledge their value and keeps its purse strings tightly closed.

The chancellor, Rishi Sunak, was forthright in his budget about the government’s commitment to helping the NHS deal with the Covid-19 crisis: “Whatever extra resources our NHS needs to cope with Covid-19, it will get. Whatever it needs, whatever it costs, we stand behind our NHS.”

This is to be welcomed, and he has put aside £5 billion for this purpose. Community pharmacies across the country are facing the same pressures as their NHS colleagues, the same risks to staff health, the same unbudgeted costs – but they are private businesses contracted to the NHS, and not a penny has been put aside for them.

As the negotiator, me and my team are working to get phar­macies the financial support they need. And while they get on with the job they have been trained to do, we should value equally all our frontline healthcare staff. The selflessness, dedi­cation, resilience and bravery of community pharmacy teams deserve our full support.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less